About Novavax Company
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Novavax, Inc.'s (NASDAQ:NVAX) Latest 7.4% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
To get a sense of who is truly in control of Novavax, Inc. (NASDAQ:NVAX), it is important to understand the ownership structure of the business.
Updated COVID Boosters to Divide America
Two new national polls indicate a mixed reaction with a partisan divide among Americans on the need for updated COVID boosters that the U.S. regulators recently cleared for a fall immunization drive.
Novavax to Get European Watchdog's Ruling on Updated COVID Vaccine Use in October
The European Medicines Agency is poised to rule on the use of Novavax's (NVV1.F) updated COVID-19 vaccine in October, Reuters reported Thursday, citing a statement by the agency's director Emer Cooke.